Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)

v3.20.2
SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2019
Aug. 14, 2020
Net Loss Per Common Share        
Shares excluded from the calculation of weighted average dilutive common shares   7,325,993 918,294  
Number of warrants exercisable (in shares)   1,235,977    
Warrants term (in years) 5 years 5 years   5 years
Warrants to purchase common stock 1,235,977 1,235,977    
Exercise price of warrants (in dollars per share) $ 5.50 $ 5.50   $ 5.50
Aggregate of common stock and warrant to purchase 1,555,313      
Common stock issued on conversion of outstanding 1,461,090      
Stock options        
Net Loss Per Common Share        
Shares excluded from the calculation of weighted average dilutive common shares   96,721 54,333  
Warrants        
Net Loss Per Common Share        
Shares excluded from the calculation of weighted average dilutive common shares   7,229,272 843,889  
Convertible Notes Payable        
Net Loss Per Common Share        
Shares excluded from the calculation of weighted average dilutive common shares   0 20,072